Bepotastine/corticosteroid intranasal - ISTA Pharmaceuticals

Drug Profile

Bepotastine/corticosteroid intranasal - ISTA Pharmaceuticals

Alternative Names: Beposone; Bepotastine besilate/steroid; Steroid/bepotastine intranasal - ISTA Pharmaceuticals

Latest Information Update: 19 Aug 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ISTA Pharmaceuticals
  • Class Antiallergics; Antihistamines; Corticosteroids; Piperidines; Pyridines; Small molecules; Steroids
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Seasonal allergic rhinitis

Most Recent Events

  • 05 Aug 2013 Bausch & Lomb has been acquired by Valeant Pharmaceuticals International
  • 06 Jun 2012 ISTA Pharmaceuticals has been acquired by Bausch & Lomb
  • 01 May 2012 Final efficacy and adverse events data from a phase II trial in Seasonal allergic rhinitis released by ISTA Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top